Table 2.

The selected synergistic point in MMB + CFM-4.16 combination with its CI in both MDA-MB-231 and MDA-MB-468 where MMB is momelotinib.

Combo	Dose		CI MDA-MB-231	CI MDA-MB-468
	MMB	CFM-4.16
MMB + CFM-4.16	1.5 µM	12.5 µM	0.58	0.19